Medical News on Cancer
Trastuzumab Emtansine (T-DM1) Significantly Improves Breast Cancer Survival
Aug 27, 2012
The investigational drug, Trastuzumab Emtansine (T-DM1), improves survival of patients with HER2-Positive metastatic breast cancer "significantly", Genentech Inc. announced today as it published highlights of its Phase III EMILIA study results. T-DM1 was compared to lapatinib and Xeloda (capecitabine) combination therapy... Read More
Since The Introduction Of PSA Testing, Prostate Cancer Survival Rates Have Improved
Aug 27, 2012
The routine use of prostate specific antigen (PSA) testing for screening and monitoring prostate cancer has led to early and more sensitive detection of the disease... Read More
Racial Disparities In Prostate Cancer Care
Aug 27, 2012
A study led by investigators from Vanderbilt-Ingram Cancer Center (VICC), Nashville, Tenn., finds that black men with prostate cancer receive lower quality surgical care than white men. The racial differences persist even when controlling for factors such as the year of surgery, age, comorbidities and insurance status. Daniel Barocas, M.D... Read More
Human Melanoma Stem Cells Identified
Aug 27, 2012
Cancer stem cells are defined by three abilities: differentiation, self-renewal and their ability to seed a tumor. These stem cells resist chemotherapy and many researchers posit their role in relapse... Read More
News From The Journals Of The American Society For Microbiology: August 2012
Aug 26, 2012
Boost for Efforts to Prevent Microbial Stowaways on Interplanetary Spacecraft Efforts to expunge micro-organisms from spacecraft assembly cleanrooms, and the spacecraft themselves, inadvertently select for the organisms that are often the most fit to survive long journeys in space... Read More
PSA Testing For Screening Prostate Cancer Has Improved Survival Rates
Aug 24, 2012
According to a new study published in The Journal of Urology, the introduction of prostate specific antigen (PSA) testing for screening and monitoring prostate cancer has improved survival rates for patients whose disease has metastasized to other areas of the body. In addition, PSA testing has resolved the disparity between African American and Caucasian men. Lead researcher Ian M... Read More
Unique Adverse Events With Newly Approved Drug Reviewed By Melanoma Expert
Aug 24, 2012
An internationally recognized melanoma researcher at Moffitt Cancer Center and colleagues at the University of Kiel in Germany, including Axel Hauschild, M.D., and Katharina C. Kahler, M.D., have published an article in the Journal of Clinical Oncology that describes immune-related adverse events for patients receiving either tremelimumab or ipilimumab... Read More
Intravenous Administration Of Green Tea Compound Shows Promise For Tackling Cancer
Aug 24, 2012
A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland. The extract, known as epigallocatechin gallate, has been known to have preventative anti-cancer properties but fails to reach tumours when delivered by conventional intravenous administration... Read More
Blood Cells Returned To Stem Cell State
Aug 24, 2012
Johns Hopkins scientists have developed a reliable method to turn the clock back on blood cells, restoring them to a primitive stem cell state from which they can then develop into any other type of cell in the body... Read More
What Is Blood Sugar? What Is Blood Glucose?
Aug 24, 2012
Blood sugar or blood glucose refers to sugar that is transported through the bloodstream to supply energy to all the cells in our bodies. The sugar is made from the food we eat... Read More
Previous Page Next Page